AzTrials
AzTrials

Mechanical Ventilation WeaningNCT05539599

Comprehensive Ultrasound Evaluation as a Predictor of Weaning

An observational study of Mechanical Ventilation Weaning and Weaning Failure, run by Università degli Studi di Ferrara at 2 sites in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Several studies investigated the role of specific clinical predictors of weaning success, but it is determined by a combination of different aspects that can result in success or failure. Read more about this study

Who is it for?
Ages 18 to 90 years
What is being tested?
Comprehensive evaluation
How many people
89 participants
Where
2 sitesItaly
Study dates
9 Sep 2022to 8 May 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: mechanically ventilated patients

Who may be able to join

  • aged between 18 and 90 years
  • Mechanical ventilation> 48 h
  • Reason for ICU admission: medical / surgical / trauma

Who cannot join

  • age under 18
  • diagnosis of neuromuscular disease
  • tracheostomy
  • terminal extubation
  • pregnancy in progress -
  • previous paralysis of the diaphragm or of a hemidiaphragm
  • use of neuromuscular blocking drugs in continuous infusion in the 48 hours preceding the weaning attempt.
  • Refusal to participate in the study

Trial locations and contacts

2 sites in 1 country.

Italy2 sites
  • Università di Ferrara

    Ferrara, 44121

  • Università di Siena

    Siena, 53100

Other trials in Italy

About this study

Official title: Can Heart-lung-respiratory Muscles Ultrasound Evaluation Play a Role to Predict Weaning in Critically Ill Patients?

Several studies investigated the role of specific clinical predictors of weaning success, but it is determined by a combination of different aspects that can result in success or failure. Indeed, unresolved lung disease, cardiac dysfunction, loss of respiratory and core muscle strength can play a role in a failure weaning to mechanical ventilation (MV). The investigators hypothesized that a combined score that include heart, lung, and respiratory muscle ultrasound (US) evaluation could be able to predict the ability of weaning success. Furthermore, it will be described weather the days of MV before weaning trial may affect the relevance of each clinical variable evaluated.

Read the detailed description

Critically ill patients undergone at least 48 hours of MV and ready to spontaneous breathing trial (SBT) will be included in the study. The spontaneous breathing trial is performed in pressure support ventilation with a clinician-set positive end expiratory pressure (PEEP) ≤ 5 cm H2O and FiO2< 40%. In addition to the parameters traditionally used for the evaluation of weaning (RSBI), the investigators will perform ultrasound evaluation of diaphragm, lung parenchyma, cardiac function, and the strength of the hand grip.

Investigators will evaluate the diaphragmatic parameters (thickening fraction,TF, and diaphragmatic displacement, DD) and TFmax (TF during forced breathing /TF during tidal respiration) to identify the inspiratory reserve. Weaning success is considered as liberation from MV within 72 hours.

Being tested
Comprehensive evaluation
Keywords
weaning, MV critically ill patients, Ultrasound evaluation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Comprehensive evaluationDiagnostic test

    Non-ultrasound parameters: Central venous pressure, hand-grip strength evaluation, P0.1, Maximal inspiratory pressure, Blood gas analysis ultrasound parameters: Diaphragmatic displacement, thickening fraction, TFmax, E/e', Triscuspidal annular Plane Systolic Excursion, Lung score

Study groups in NCT05539599
Study groupRoleWhat they receive
CohortPatients will undergo a spontaneous breathing trial. Any extubation will be decided by an independent operator.
Receives: Diagnostic Test: Comprehensive evaluation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessing the prognostic value of a combined score in predicting weaning success

    We hypothesized that a combined score that include heart, lung, and respiratory muscle ultrasound (US) evaluation could be able to predict the ability of weaning success.

    Measured: 72 hours

Secondary outcomes (1)
  1. Interaction between days of mechanical ventilator and determinant of weaning success

    We will assess the interaction between days of mechanical ventilation and the prognostic value of Central venous pressure, hand-grip strength evaluation, P0.1, Maximal inspiratory pressure, Blood gas analysis, Diaphragmatic displacement, thickening fraction, TFmax, E/e', Triscuspidal annular Plane Systolic Excursion, Lung score in predicting weaning success

    Measured: 28 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Sep 2022
  2. Study start9 Sep 2022
  3. Primary completion2 May 2024
  4. Study completion8 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
89 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05539599
Sponsor's protocol ID
WEAN_US
Status last verified
May 2024
First submitted
8 Sep 2022
Last updated
9 May 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Fogagnolo A, Dres M, Murgolo F, Grasso S, Brazzoli B, Pasa G, Khan MR, Azzolina D, Alvisi V, Scaramuzzo G, Volta CA, Spadaro S. Integrated comprehensive assessment for predicting weaning success in difficult-to-wean critically ill patients: the WEAN-US study. Crit Care. 2026 Jun 4;30(1):309. doi: 10.1186/s13054-026-06113-7.

    PubMed 42243858

Questions about this trial

What is this clinical trial studying?

An observational study of Mechanical Ventilation Weaning and Weaning Failure, run by Università degli Studi di Ferrara at 2 sites in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessing the prognostic value of a combined score in predicting weaning success (time frame: 72 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05539599, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in